Observational Non-interventional Study With Viramune® in Combination With Truvada® in HIV-infected Patients

CompletedOBSERVATIONAL
Enrollment

334

Participants

Timeline

Start Date

February 28, 2006

Primary Completion Date

December 31, 2009

Conditions
HIV Infections
Trial Locations (63)

Unknown

Boehringer Ingelheim Investigational Site, Aachen

1100.1492.1 Boehringer Ingelheim Investigational Site, Berlin

Boehringer Ingelheim Investigational Site 10, Berlin

Boehringer Ingelheim Investigational Site 11, Berlin

Boehringer Ingelheim Investigational Site 12, Berlin

Boehringer Ingelheim Investigational Site 13, Berlin

Boehringer Ingelheim Investigational Site 14, Berlin

Boehringer Ingelheim Investigational Site 1, Berlin

Boehringer Ingelheim Investigational Site 2, Berlin

Boehringer Ingelheim Investigational Site 3, Berlin

Boehringer Ingelheim Investigational Site 4, Berlin

Boehringer Ingelheim Investigational Site 5, Berlin

Boehringer Ingelheim Investigational Site 6, Berlin

Boehringer Ingelheim Investigational Site 7, Berlin

Boehringer Ingelheim Investigational Site 8, Berlin

Boehringer Ingelheim Investigational Site 9, Berlin

Boehringer Ingelheim Investigational Site 1, Cologne

Boehringer Ingelheim Investigational Site 2, Cologne

Boehringer Ingelheim Investigational Site 3, Cologne

Boehringer Ingelheim Investigational Site, Dortmund

Boehringer Ingelheim Investigational Site, Duisburg

Boehringer Ingelheim Investigational Site 1, Düsseldorf

Boehringer Ingelheim Investigational Site 2, Düsseldorf

Boehringer Ingelheim Investigational Site, Frankfurt (Oder)

Boehringer Ingelheim Investigational Site 1, Frankfurt am Main

Boehringer Ingelheim Investigational Site 2, Frankfurt am Main

Boehringer Ingelheim Investigational Site 3, Frankfurt am Main

Boehringer Ingelheim Investigational Site 4, Frankfurt am Main

Boehringer Ingelheim Investigational Site, Freiburg im Breisgau

Boehringer Ingelheim Investigational Site 1, Hamburg

Boehringer Ingelheim Investigational Site 2, Hamburg

Boehringer Ingelheim Investigational Site 3, Hamburg

Boehringer Ingelheim Investigational Site 4, Hamburg

Boehringer Ingelheim Investigational Site 1, Hanover

Boehringer Ingelheim Investigational Site 2, Hanover

Boehringer Ingelheim Investigational Site, Karlsruhe

Boehringer Ingelheim Investigational Site, Koblenz

Boehringer Ingelheim Investigational Site 1, Leipzig

Boehringer Ingelheim Investigational Site 2, Leipzig

Boehringer Ingelheim Investigational Site, Magdeburg

Boehringer Ingelheim Investigational Site, Mainz

Boehringer Ingelheim Investigational Site, Mannheim

Boehringer Ingelheim Investigational Site 1, München

Boehringer Ingelheim Investigational Site 2, München

Boehringer Ingelheim Investigational Site 3, München

Boehringer Ingelheim Investigational Site 4, München

Boehringer Ingelheim Investigational Site 5, München

Boehringer Ingelheim Investigational Site 1, Münster

Boehringer Ingelheim Investigational Site 2, Münster

Boehringer Ingelheim Investigational Site 3, Münster

Boehringer Ingelheim Investigational Site 4, Münster

Boehringer Ingelheim Investigational Site 1, Nuremberg

Boehringer Ingelheim Investigational Site 2, Nuremberg

Boehringer Ingelheim Investigational Site, Oldenburg

Boehringer Ingelheim Investigational Site, Osnabrück

Boehringer Ingelheim Investigational Site, Potsdam

Boehringer Ingelheim Investigational Site, Saarbrücken

Boehringer Ingelheim Investigational Site 1, Stuttgart

Boehringer Ingelheim Investigational Site 2, Stuttgart

Boehringer Ingelheim Investigational Site 3, Stuttgart

Boehringer Ingelheim Investigational Site, Troisdorf

Boehringer Ingelheim Investigational Site, Wiesbaden

Boehringer Ingelheim Investigational Site, Wuppertal

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT00543803 - Observational Non-interventional Study With Viramune® in Combination With Truvada® in HIV-infected Patients | Biotech Hunter | Biotech Hunter